News and Announcements
Newground Capital Partners announce financial close in Canberra
- Published June 04, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Newground Capital Partners is pleased to announce the financial close of a mezzanine debt facility for a residential apartment development in Canberra.
Newground secured the senior lender in addition to its funding to assist the developer in the construction of 78 apartments with a healthy level of pre-sales in place.
“This is an example where Newground was prepared to take some market risk on a quality project which is well located, thoughtfully designed and attractive to a range of buyers.”
– Stephen Hall, Newground Capital Partners
About Newground Capital:
Newground Capital Partners are real estate debt & equity partners. The company invests across all sectors of real estate development alongside proven sponsors who require additional capital to grow and execute their project pipeline. Newground provides investors with access to off-market proprietary deal flow, genuine alignment of interest via co-investment, combined with years of experience and a proven track record.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
